Temporal echocardiography findings in patients with fulminant myocarditis: beyond ejection fraction decline

Abstract

The features of myocardial strains from speckle-tracking echocardiography (STE) have not been well defined in fulminant myocarditis (FM) patients. In this study, changes in the left ventricular ejection fraction (LVEF) and global and layer-specific myocardial strains over time were monitored. We aimed to determine the echocardiographic patterns of FM and ascertain their significance in FM treatment. Twenty patients who were clinically diagnosed with FM and received mechanical life support were prospectively enrolled. Conventional echocardiographic measurements were obtained, and serial strain echocardiography was performed from admission to hospital discharge until LVEF recovery (>50%). Global/regional peak systolic longitudinal strains (GLS/RLS) and layer-specific longitudinal strains were quantified, and their changes with time were monitored in 14 FM patients. All patients had severely impaired cardiac function. Steep improvement in LVEF and GLS were observed within 6 days. Layer-specific strain analysis showed that reduction at admission or recovery at discharge in the endocardium and epicardium strains were equal. In conclusion, FM patients who received mechanical circulatory supports exhibited steep improvement in ventricular function within 6 days. The patchy and diffused distribution pattern of reduced RLS and equally and severely impaired strain in the endocardium and epicardium are valuable features in the diagnosis of FM.

Keywords

fulminant myocarditis / acute myocarditis / 2D speckle tracking echocardiography / left ventricular function / global longitudinal strain

References

[1] Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet 2012; 379(9817): 738–747

[2] Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1(1): 3–14

[3] Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res 2016; 118(3): 496–514

[4] Chen YS, Yu HY, Huang SC, Lin JW, Chi NH, Wang CH, Wang SS, Lin FY, Ko WJ. Extracorporeal membrane oxygenation support can extend the duration of cardiopulmonary resuscitation. Crit Care Med 2008; 36(9): 2529–2535

[5] Chung SY, Sheu JJ, Lin YJ, Sun CK, Chang LT, Chen YL, Tsai TH, Chen CJ, Yang CH, Hang CL, Leu S, Wu CJ, Lee FY, Yip HK. Outcome of patients with profound cardiogenic shock after cardiopulmonary resuscitation and prompt extracorporeal membrane oxygenation support. A single-center observational study. Circ J 2012; 76(6): 1385–1392

[6] Saito S, Toda K, Miyagawa S, Yoshikawa Y, Hata H, Yoshioka D, Domae K, Tsukamoto Y, Sakata Y, Sawa Y. Diagnosis, medical treatment, and stepwise mechanical circulatory support for fulminat myocarditis. J Artif Organs 2018; 21(2): 172–179

[7] Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, Petrella D, Garascia A, Pedrotti P, Roghi A, Bonacina E, Moreo A, Bottiroli M, Gagliardone MP, Mondino M, Ghio S, Totaro R, Turazza FM, Russo CF, Oliva F, Camici PG, Frigerio M. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation 2017; 136(6): 529–545

[8] Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, Esmailian F, Azarbal B. Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: a weighted meta-analysis of 170 patients. J Card Fail 2014; 20(6): 400–406

[9] McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342(10): 690–695

[10] Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 2000; 36(1): 227–232

[11] Li S, Xu S, Li C, Ran X, Cui G, He M, Miao K, Zhao C, Yan J, Hui R, Zhou N, Wang Y, Jiang J, Zhang J, Wang D. A life support-based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis: a multiple center study. Sci China Life Sci 2019; 62(3): 369–380

[12] Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R; American Heart Association; American College of Cardiology; European Society of Cardiology; Heart Failure Society of America; Heart Failure Association of the European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. J Am Coll Cardiol 2007; 50(19): 1914–1931

[13] Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009; 53(17): 1475–1487

[14] Gorcsan J 3rd, Tanaka H. Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 2011; 58(14): 1401–1413

[15] Zuo H, Yan J, Zeng H, Li W, Li P, Liu Z, Cui G, Lv J, Wang D, Wang H. Diagnostic power of longitudinal strain at rest for the detection of obstructive coronary artery disease in patients with type 2 diabetes mellitus. Ultrasound Med Biol 2015; 41(1): 89–98

[16] Løgstrup BB, Nielsen JM, Kim WY, Poulsen SH. Myocardial oedema in acute myocarditis detected by echocardiographic 2D myocardial deformation analysis. Eur Heart J Cardiovasc Imaging 2016; 17(9): 1018–1026

[17] Caspar T, Germain P, El Ghannudi S, Morel O, Samet H, Trinh A, Petit-Eisenmann H, Talha S, Fichot M, Jesel L, Ohlmann P. Acute myocarditis diagnosed by layer-specific 2D longitudinal speckle tracking analysis. Echocardiography 2016; 33(1): 157–158

[18] Section of Precision Medical of Chinese Society of Cardiology of Chinese Medical Association; Editorial Board of Chinese Journal of Cardiology; Working Group on Adult Myocarditis. Chinese expert consensus statement on clinical diagnosis and treatment of fulminant myocarditis in adults. Chin J Cardiol (Zhonghua Xin Xue Guan Bing Za Zhi) 2017; 45: 742–752 (in Chinese)

[19] Wang D, Li S, Jiang J, Yan J, Zhao C, Wang Y, Ma Y, Zeng H, Guo X, Wang H, Tang J, Zuo H, Lin L, Cui G; Section of Precision Medicine Group of Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology & Working Group of Adult Fulminant Myocarditis. Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis. Sci China Life Sci 2019; 62(2):187–202

[20] Jing Z, Hang W, Hui R, Zhao Q, Desai S. China’s treatment regimen for fulminant myocarditis is bringing wonderful achievement to the world. Sci China Life Sci 2019; 62(2):282–284

[21] Edin M, Zeldin D. An improved protocol for the treatment of fulminant myocarditis. Sci China Life Sci 2019; 62(3):433–434

[22] Maisch B, Ruppert V, Pankuweit S. Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options. Curr Heart Fail Rep 2014; 11(2): 166–177

[23] Ammirati E, Cipriani M, Camici PG. New concepts in fulminant myocarditis and risk of cardiac mortality. Oncotarget 2017; 8(49): 84624–84625

[24] Hsiao JF, Koshino Y, Bonnichsen CR, Yu Y, Miller FA Jr, Pellikka PA, Cooper LT Jr, Villarraga HR. Speckle tracking echocardiography in acute myocarditis. Int J Cardiovasc Imaging 2013; 29(2): 275–284

[25] Heymans S, Eriksson U, Lehtonen J, Cooper LT Jr. The quest for new approaches in myocarditis and inflammatory cardiomyopathy. J Am Coll Cardiol 2016; 68(21): 2348–2364

[26] Escher F, Kasner M, Kühl U, Heymer J, Wilkenshoff U, Tschöpe C, Schultheiss HP. New echocardiographic findings correlate with intramyocardial inflammation in endomyocardial biopsies of patients with acute myocarditis and inflammatory cardiomyopathy. Mediators Inflamm 2013; 2013: 875420

[27] Longobardo L, Todaro MC, Zito C, Piccione MC, Di Bella G, Oreto L, Khandheria BK, Carerj S. Role of imaging in assessment of atrial fibrosis in patients with atrial fibrillation: state-of-the-art review. Eur Heart J Cardiovasc Imaging 2014; 15(1): 1–5

[28] Lurz P, Eitel I, Klieme B, Luecke C, de Waha S, Desch S, Fuernau G, Klingel K, Kandolf R, Grothoff M, Schuler G, Gutberlet M, Thiele H. The potential additional diagnostic value of assessing for pericardial effusion on cardiac magnetic resonance imaging in patients with suspected myocarditis. Eur Heart J Cardiovasc Imaging 2014; 15(6): 643–650

[29] Robinson JL, Hartling L, Crumley E, Vandermeer B, Klassen TP. A systematic review of intravenous gamma globulin for therapy of acute myocarditis. BMC Cardiovasc Disord 2005; 5(1): 12

[30] Bhatt GC, Sankar J, Kushwaha KP. Use of intravenous immunoglobulin compared with standard therapy is associated with improved clinical outcomes in children with acute encephalitis syndrome complicated by myocarditis. Pediatr Cardiol 2012; 33(8): 1370–1376

[31] Schulz-Menger J, Maisch B, Abdel-Aty H, Pankuweit S. Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers—a stepwise approach for diagnosis and treatment. Herz 2007; 32(6): 458–472

[32] Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009; 30(16): 1995–2002

[33] Asaumi Y, Yasuda S, Morii I, Kakuchi H, Otsuka Y, Kawamura A, Sasako Y, Nakatani T, Nonogi H, Miyazaki S. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J 2005; 26(20): 2185–2192

RIGHTS & PERMISSIONS

Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature